Green Financial Statements From 2010 to 2024

142280 Stock  KRW 3,660  85.00  2.27%   
Green Cross financial statements provide useful quarterly and yearly information to potential Green Cross Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Green Cross financial statements helps investors assess Green Cross' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Green Cross' valuation are summarized below:
Green Cross Medical does not presently have any fundamental trends for analysis.
Check Green Cross financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Green Cross' main balance sheet or income statement drivers, such as , as well as many indicators such as . Green financial statements analysis is a perfect complement when working with Green Cross Valuation or Volatility modules.
  
This module can also supplement various Green Cross Technical models . Check out the analysis of Green Cross Correlation against competitors.

Green Cross Medical Company Current Valuation Analysis

Green Cross' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Green Cross Current Valuation

    
  272.85 B  
Most of Green Cross' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cross Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Green Cross Medical has a Current Valuation of 272.85 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

Green Cross Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Green Cross's current stock value. Our valuation model uses many indicators to compare Green Cross value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Cross competition to find correlations between indicators driving Green Cross's intrinsic value. More Info.
Green Cross Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Green Cross by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Green Cross' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Green Cross Financial Statements

Green Cross stakeholders use historical fundamental indicators, such as Green Cross' revenue or net income, to determine how well the company is positioned to perform in the future. Although Green Cross investors may analyze each financial statement separately, they are all interrelated. For example, changes in Green Cross' assets and liabilities are reflected in the revenues and expenses on Green Cross' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Green Cross Medical. Please read more on our technical analysis and fundamental analysis pages.
GreenCross Medical Science Corp. manufactures and sells diagnostic reagents in South Korea. The company was founded in 2003 and is headquartered in Yongin, South Korea. GCMS is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Green Cross

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Green Cross position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cross will appreciate offsetting losses from the drop in the long position's value.

Moving against Green Stock

  0.39041190 Woori Technology InvPairCorr
The ability to find closely correlated positions to Green Cross could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Green Cross when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Green Cross - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Green Cross Medical to buy it.
The correlation of Green Cross is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Green Cross moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Green Cross Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Green Cross can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Green Stock

Green Cross financial ratios help investors to determine whether Green Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Green with respect to the benefits of owning Green Cross security.